Table 6 Number of patients and events according to trial group
Number of patients (percentage) | |||
|---|---|---|---|
CCLG N = 210 | GPOH N = 437 | Total | |
First events (total) | 119 (57) | 204 (47) | 323 |
Death-treatment related | 1 (0.5) | 3 (1) | 4 |
Disease progression | 3 (1) | 12 (3) | 15 |
Unknown cause | 3 (1) | 1 (0.2) | 3 |
Distant metastases | 66 (31) | 148 (34) | 214 |
[Distant metastases in those with metastatic disease at baseline] | [25 (12%)] | [57 (13%)] | [82] |
Local relapse | 29 (14) | 13 (3) | 42 |
Local and distant relapse | 16 (8) | 18 (4) | 34 |
Relapse (unspecified site) | 0 | 4 (1) | 4 |
Second malignancy | 2 (1) | 5 (1) | 7 |
All deaths | 105 (50) | 168 (38) | 273 |